Cargando…

Opportunities for Web-based Drug Repositioning: Searching for Potential Antihypertensive Agents with Hypotension Adverse Events

BACKGROUND: Drug repositioning refers to the process of developing new indications for existing drugs. As a phenotypic indicator of drug response in humans, clinical side effects may provide straightforward signals and unique opportunities for drug repositioning. OBJECTIVE: We aimed to identify drug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Kejian, Wan, Mei, Wang, Rui-Sheng, Weng, Zuquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications Inc. 2016
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833875/ https://www.ncbi.nlm.nih.gov/pubmed/27036325 http://dx.doi.org/10.2196/jmir.4541

Ejemplares similares

Older Age, Polypharmacy, and Low Systolic Blood Pressure Are Associated With More Hypotension-Related Adverse Events in Patients With Type 2 Diabetes Treated With Antihypertensives
por: Ambrož, Martina, et al.
Publicado: (2021)

Drug repositioning prediction for psoriasis using the adverse event reporting database
por: Ko, Minoh, et al.
Publicado: (2023)

A comprehensive study of the association between drug hepatotoxicity and daily dose, liver metabolism, and lipophilicity using 975 oral medications
por: Weng, Zuquan, et al.
Publicado: (2015)

DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome
por: Luo, Heng, et al.
Publicado: (2011)

Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs
por: Rydberg, Diana M, et al.
Publicado: (2018)

Association between antihypertensive treatment and adverse events: systematic review and meta-analysis
por: Albasri, Ali, et al.
Publicado: (2021)

Systematic drug repositioning through mining adverse event data in ClinicalTrials.gov
por: Su, Eric Wen, et al.
Publicado: (2017)

Hyperuricaemia, gout and related adverse events associated with antihypertensive drugs: A real-world analysis using the FDA adverse event reporting system
por: Jiao, Xue-Feng, et al.
Publicado: (2023)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

Prediction of Drug-Target Interactions for Drug Repositioning Only Based on Genomic Expression Similarity
por: Wang, Kejian, et al.
Publicado: (2013)

Hypotensive and Antihypertensive Properties and Safety for Use of Annona muricata and Persea americana and Their Combination Products
por: Sokpe, Authentia, et al.
Publicado: (2020)

Mining integrated semantic networks for drug repositioning opportunities
por: Mullen, Joseph, et al.
Publicado: (2016)

Drug repositioning in pulmonary arterial hypertension: challenges and opportunities
por: Grinnan, Daniel, et al.
Publicado: (2019)

Challenges and Opportunities for Drug Repositioning in Fibrodysplasia Ossificans Progressiva
por: Ventura, Francesc, et al.
Publicado: (2021)

Is Use of Multiple Antihypertensive Agents to Achieve Blood Pressure Control Associated with Adverse Pregnancy Outcomes?
por: Allen, Sarah E., et al.
Publicado: (2017)

Correction: Prediction of Drug-Target Interactions for Drug Repositioning Only Based on Genomic Expression Similarity
por: Wang, Kejian, et al.
Publicado: (2013)

The association between antihypertensive treatment and serious adverse events by age and frailty: A cohort study
por: Sheppard, James P., et al.
Publicado: (2023)

Hypotensive and antihypertensive effects of an aqueous extract from Guinep fruit (Melicoccus bijugatus Jacq) in rats
por: Nwokocha, Chukwuemeka R., et al.
Publicado: (2020)

Development of Pigmentation-Regulating Agents by Drug Repositioning
por: Jeong, Seo-Mi-Gon, et al.
Publicado: (2021)

Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease
por: Corbett, Anne, et al.
Publicado: (2013)

Learning Opportunities for Drug Repositioning via GWAS and PheWAS Findings
por: Yin, Wen, et al.
Publicado: (2018)

Repositioning Clofazimine as a Macrophage-Targeting Photoacoustic Contrast Agent
por: Keswani, Rahul K., et al.
Publicado: (2016)

Turning genome-wide association study findings into opportunities for drug repositioning
por: Lau, Alexandria, et al.
Publicado: (2020)

Retrospective evaluation of labetalol as antihypertensive agent in dogs
por: Zublena, Francesco, et al.
Publicado: (2020)

Antihypertensive Prescribing for Uncomplicated, Incident Hypertension: Opportunities for Cost Savings
por: Quinn, Amity E., et al.
Publicado: (2021)

Characterization of Imidazoline Receptors in Blood Vessels for the Development of Antihypertensive Agents
por: Chen, Mei-Fen, et al.
Publicado: (2014)

Antihypertensive Agents and Risk of Parkinson's Disease: A Nationwide Cohort Study
por: Lee, Yen-Chieh, et al.
Publicado: (2014)

Investigating drug repositioning opportunities in FDA drug labels through topic modeling
por: Bisgin, Halil, et al.
Publicado: (2012)

A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions
por: Jarada, Tamer N., et al.
Publicado: (2020)

LINCS Dataset-Based Repositioning of Dutasteride as an Anti-Neuroinflammation Agent
por: Luo, Dan, et al.
Publicado: (2021)

Repositioning linifanib as a potent anti-necroptosis agent for sepsis
por: Yu, Liang, et al.
Publicado: (2023)

Circulatory therapeutics: use of antihypertensive agents and their effects on the vasculature
por: Schiffrin, Ernesto L
Publicado: (2010)

Retrospective evaluation of adverse drug reactions induced by antihypertensive treatment
por: Rende, Pierandrea, et al.
Publicado: (2013)

Uncommon Adverse Drug Reaction to a Commonly Used Antihypertensive
por: Soni, Rajesh, et al.
Publicado: (2020)

Blood pressure circadian rhythms and adverse outcomes in type 2 diabetes patients diagnosed with orthostatic hypotension
por: Chang, Jing, et al.
Publicado: (2017)

Post-induction hypotension and intraoperative hypotension as potential separate risk factors for the adverse outcome: a cohort study
por: Czajka, Szymon, et al.
Publicado: (2023)

Improving patient self-reporting of antihypertensive adverse drug events in primary care: a stepped wedge cluster randomised trial
por: Buchet-Poyau, Karine, et al.
Publicado: (2021)

Repositioning drugs for inflammatory disease – fishing for new anti-inflammatory agents
por: Hall, Christopher J., et al.
Publicado: (2014)

Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer
por: Kobayashi, Yusuke, et al.
Publicado: (2017)

Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent
por: Ayoub, Bassam M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7bfiucb5k0ioc52lhcnt790th7